Matthieu Grollemund

Matthieu Grollemund


Email [email protected]​

Phone +33 1 53 67 47 47

Fax +33 1 53 67 47 48

LanguagesEnglish, French, German

Practice groupCorporate & Finance

"One of the key point of contact for the department"

Chambers Europe 2020-2019

Matthieu Grollemund is a Corporate partner in our Paris office and a member of our global Private Equity leadership team.

Triple qualified in French, US and UK law, he is a seasoned corporate lawyer active in complex and cross-border transactions. He focuses on private equity sponsors, venture capital firms, public and private corporations, boards of directors, and special committees in their most sensitive investments, public and private M&A transactions, IPOs, amicable or hostile transactions. He is particularly known in the Tech and Healthcare industries.

Prior to joining the firm, Matthieu Grollemund was Co-Head of the Paris Corporate Department of an international law firm. He also spent five years as a partner in a US-based global law firm in the New York office.

Awards and recognitions


Corporate/M&A (France), Foreign Expert for USA
Chambers Global


Lawyers specialised in LBOs (transactions on companies worth more than €300m) and innovation capital
Option Droit & Affaires


Ranked Individuals “Private Equity: Venture Capital in France”
Chambers Europe


Foreign Expert in Corporate/M&A (France and UK)
Chambers Global


Most Innovative Lawyers in Europe
Financial Times

Education and admissions


Corporate Law, University of Paris I Panthéon-Sorbonne, 1997

M.B.A., ESCP Paris, 1995

Bar admissions and qualifications


Solicitor, England and Wales

Licensed as a Foreign Legal Consultant, New York

Representative experience

Advised on numerous major French tech transactions (Doctolib, Mirakl, Ynsect, Ledger, ManoMano, Contentsquare, Sorare, Exotec, Blablacar, Dataiku, FarFetch, Back Market, PayFit, Lydia, Criteo)


Advised on a number of IPO and international offerings (AAA, Criteo, Navya, Farfetch)*

Advised numerous tender of offers and Public M&A (Zimmer Biomet on Medtech, Medtronic on Medicrea, Stryker on Vexim, Aptar on Voluntis)


Advised on the acquisition by Arch of a 30% block in Coface*


Advised Tencent on the acquisition of a minority interest in Ubisoft from Vivendi*

Advised ADM in the acquisition of Neovia from Invivo and Eurazeo for €1.4bn*


Advised in the disposition of Maesa to Bain Capital*


Routinely advises a number of private equity funds on their growth and LBO investments mostly in the Tech, Life Science, Fintech and highly regulated industries*


*Matter handled prior to joining Hogan Lovells.

Loading data